QTTB Q4 2023 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$15M-1928.2% YoY

Gross Profit

-$15M100.0% margin

Operating Income

-$26M176.0% margin

Net Income

-$27M184.6% margin

EPS (Diluted)

$-5.00

QoQ Revenue Growth

-888.7%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$47M

Total Liabilities

$230M

Stockholders' Equity

-$183M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$15M	$802,000	-1928.2%
Gross Profit	-$15M	$169,000	-8775.7%
Operating Income	-$26M	-$34M	+25.2%
Net Income	-$27M	-$34M	+21.1%